56 related articles for article (PubMed ID: 2170577)
1. Induction of cervical neoplasia in the mouse by an extract of cells infected by varicella-zoster virus.
Heggie AD; Wentz WB; Sorensen K; Anthony DD
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2175-8. PubMed ID: 2170577
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytomegalovirus and Chlamydia trachomatis in the induction of cervical neoplasia in the mouse.
Heggie AD; Wentz WB; Reagan JW; Anthony DD
Cancer Res; 1986 Oct; 46(10):5211-4. PubMed ID: 3019522
[TBL] [Abstract][Full Text] [Related]
3. Induction of cervical neoplasia in the mouse by herpes simplex virus type 2 DNA.
Anthony DD; Wentz WB; Reagan JW; Heggie AD
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4520-4. PubMed ID: 2543981
[TBL] [Abstract][Full Text] [Related]
4. Failure to induce cervical cancer in mice by long-term frequent vaginal exposure to live or inactivated herpes simplex viruses.
Meignier B; Norrild B; Thuning C; Warren J; Frenkel N; Nahmias AJ; Rapp F; Roizman B
Int J Cancer; 1986 Sep; 38(3):387-94. PubMed ID: 3017867
[TBL] [Abstract][Full Text] [Related]
5. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency.
Cohen JI; Krogmann T; Ross JP; Pesnicak L; Prikhod'ko EA
J Virol; 2005 Jun; 79(11):6969-75. PubMed ID: 15890936
[TBL] [Abstract][Full Text] [Related]
6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
7. Acute and persistent varicella-zoster virus infection of human and murine neuroblastoma cell lines.
Bourdon-Wouters C; Merville-Louis MP; Sadzot-Delvaux C; Marc P; Piette J; Delrée P; Moonen G; Rentier B
J Neurosci Res; 1990 May; 26(1):90-7. PubMed ID: 2162972
[TBL] [Abstract][Full Text] [Related]
8. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
9. Imaging of the varicella zoster virion in the viral highways: comparison with herpes simplex viruses 1 and 2, cytomegalovirus, pseudorabies virus, and human herpes viruses 6 and 7.
Padilla JA; Nii S; Grose C
J Med Virol; 2003; 70 Suppl 1():S103-10. PubMed ID: 12627497
[TBL] [Abstract][Full Text] [Related]
10. Induction of uterine cancer with inactivated herpes simplex virus, types 1 and 2.
Wentz WB; Reagan JW; Heggie AD; Fu YS; Anthony DD
Cancer; 1981 Oct; 48(8):1783-90. PubMed ID: 6269724
[TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus infection of diploid and chemically transformed guinea-pig embryo cells: factors influencing virus replication.
Edmond BJ; Grose C; Brunell PA
J Gen Virol; 1981 Jun; 54(Pt 2):403-7. PubMed ID: 6270257
[TBL] [Abstract][Full Text] [Related]
12. Cervical carcinoma: an experimental approach.
Cowan ME; Skinner GR
Cancer Surv; 1988; 7(3):469-79. PubMed ID: 2853998
[TBL] [Abstract][Full Text] [Related]
13. A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.
Gershon AA; Chen J; Gershon MD
J Infect Dis; 2008 Mar; 197 Suppl 2():S61-5. PubMed ID: 18419411
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
Meng XJ
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
[TBL] [Abstract][Full Text] [Related]
15. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
16. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency.
Sato H; Pesnicak L; Cohen JI
J Med Virol; 2003; 70 Suppl 1():S79-81. PubMed ID: 12627493
[TBL] [Abstract][Full Text] [Related]
17. Latency in vitro of varicella-zoster virus in cells derived from human fetal dorsal root ganglia.
Somekh E; Tedder DG; Vafai A; Assouline JG; Straus SE; Wilcox CL; Levin MJ
Pediatr Res; 1992 Dec; 32(6):699-703. PubMed ID: 1337586
[TBL] [Abstract][Full Text] [Related]
18. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
19. Deoxythymidine kinases in varicella-zoster virus infected and biochemically transformed cells.
Ogino T; Lopetegui P; Yamanishi K
Biken J; 1982 Sep; 25(3):149-56. PubMed ID: 6299267
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
